Comgest Global Investors S.A.S. Nevro Corp Transaction History

Comgest Global Investors S.A.S.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$35.52 - $62.62 $1.29 Million - $2.27 Million	-36,200 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$44.22 - $75.47 $362,604 - $618,854	-8,200 Reduced 18.47%	36,200 $2.06 Million
Q1 2018 May 14, 2018	BUY	$69.46 - $88.57 $347,299 - $442,849	5,000 Added 12.69%	44,400 $3.85 Million
Q4 2017 Feb 09, 2018	BUY	$65.94 - $93.31 $2.6 Million - $3.68 Million	39,400	39,400 $2.72 Million

151

39.1M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $159M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Comgest Global Investors S.A.S., based on Form 13F filings with the SEC.

Stay updated on Comgest Global Investors S.A.S. with notifications on news.